News and Updates

image of Healthcare Common Procedure Coding System (HCPCS) reimbursement code G0183 that allows for reimbursement of HeartLung.Ai's AutoChamber™ and the CMS.gov and HeartLung.AI logos

HeartLung Technologies Secures CMS Reimbursement for AutoChamber™ with New HCPCS Code

CMS has approved a new HCPCS code for AutoChamber™ AI reporting cardiac chambers volume and left ventricular mass in existing CT scans.

Apr 22 min read

portrait photograph of Dr. Zahi A. Fayad, PhD

HeartLung Technologies welcomes medical imaging and bioengineering expert Dr. Zahi A. Fayad, PHD, to the Advisory Board

HeartLung Technologies welcomes medical imaging and bioengineering expert Dr. Zahi A. Fayad, PHD, to the Advisory Board.

Mar 253 min read

HeartLung Technologies Presented 3 Groundbreaking AI Studies at BMEII 2025 New York Academy of Medicine

HeartLung showcases AI innovations at BMEII 2025, advancing healthcare with three scientific presentations.

Mar 182 min read

HeartLung Technologies to launch AutoChamber™ AI at ACC 2025 and begin offering the AI services to healthcare providers

Mar 183 min read

HeartLung Technologies Selected as a Finalist for ACC 2025 Innovation Pitch Challenge

Mar 183 min read

SimonMed Imaging Partners with HeartLung.AI to Offer Artificial Intelligence-Based Osteoporosis Screening (AutoBMD™ AI) as an add-on to CT Scans Nationwide

SimonMed Imaging partners with HeartLung.AI to roll out AutoBMD™ AI for osteoporosis screening, enhancing preventive healthcare.

Feb 185 min read

Harmonizing Healthcare and Innovation: HeartLung Technologies Welcomes Dr. Robert A. Kloner to the Advisory Board

HeartLung Technologies welcomes Dr. Robert A. Kloner to the Advisory Board. Discover his contributions to heart health and his music.

Jan 235 min read

HeartLung’s 2024 Year in Review - Milestones and Pipeline for 2025

2024 was a monumental year for HeartLung Technologies. With that being said, we have exciting developments for 2025!

Jan 165 min read

HeartLung's distinguished advisor, Dr. Claudia Henschke, who pioneered lung cancer screening, wins the RSNA 2024 Scientific Excellence Award 🏆⚕️

HeartLung collaborator, Dr. Claudia Henschke, has been honored with the prestigious Scientific Excellence Award at #RSNA2024!

Dec 11, 20241 min read

HeartLung Technologies to Present Four Scientific Research Studies on AI-CAC™, AutoBMD™, and AI-CVD™ at the 2024 Radiological Society of North America (RSNA 2024)

HeartLung is the only AI company participating in RSNA 2024 as a scientific presenter of research studies and as an industry exhibitor

Dec 2, 20244 min read

HeartLung Technologies Presented AI-CAC™ and AI-CVD™ Research Studies at the Annual Scientific Sessions of the American Heart Association 2024

Innovative AI-enabled research studies led by HeartLung’s founder Dr. Morteza Naghavi show life-saving potential for primary prevention...

Nov 18, 20244 min read

HeartLung Technologies Receives FDA “Breakthrough” Designation and Marketing Authorization for AutoChamber™

The First AI that Enables Opportunistic Detection of Hidden Heart Disease in Millions of CT Scans SUMMARY: HeartLung Technologies (...

Oct 28, 20248 min read

Seven Groundbreaking AI-Enabled Research Studies to be Presented at the Annual Congress of the European Society of Cardiology 2024 in London

Pioneering research by Dr. Naghavi's team from American Heart Technologies and HeartLung.AI highlights AI's transformative impact on...

Aug 30, 20243 min read

HeartLung's AI-Enabled AutoChamber™ Selected as SCCT 2023 Best Abstract Award Finalist 🏆⚕️

HeartLung's AI-Enabled AutoChamber™ Selected as SCCT 2023 Best Abstract Award Finalist

Jul 31, 20231 min read

Updates from 'X' (Twitter)

Contact

contact@heartlung.ai

(310) 510-6004

Company

HeartLung Corporation

Resources

2450 Holcombe Blvd
TMC Innovations
Houston, TX 77021

©2025 HeartLung Corporation. All Rights Reserved. US Patent Nos US9119590*, US10695022, US11610686. and Patents Pending. AutoBMD™, AutoCAC™, AutoChamber™ and other trademarks shown on this website are protected under intellectual property rights of HeartLung Corporation in the United States.